Literature DB >> 31911534

Defining the learning curve for successful staging with sentinel lymph node biopsy for endometrial cancer among surgeons at an academic institution.

Katherine Tucker1, Stuart-Allison Staley2, Paola A Gehrig2, John T Soper2, John F Boggess2, Anastasia Ivanova3, Emma Rossi2.   

Abstract

BACKGROUND: Sentinel lymph node (SLN) biopsy is increasingly used in endometrial cancer staging; however, success of the technique is variable, and the learning curve needs to be better understood. Success is defined as identification of a SLN specimen containing nodal tissue in bilateral hemi-pelvises.
OBJECTIVE: To assess the learning curve of surgeons at an academic institution in performing successful SLN mapping and biopsy during robotic staging for endometrial cancer.
METHODS: After institutional review board approval, patients who underwent staging with robotic SLN mapping using indocyanine green at a single academic program between July 2012 and December 2017 were identified. Demographic, pathologic, and surgical data were retrospectively collected from the medical records. Descriptive and comparative statistics were performed. Surgeon rates of successful bilateral SLN mapping and removal of lymphoid-containing SLN specimens were compared. A logistic model was used to analyze the probability of successful SLN mapping and removal of lymph node-containing tissue with increasing number of procedures performed.
RESULTS: Three hundred and seventeen patients met the eligibility criteria. Most had early-stage, low-grade endometrial cancer. A total of 194 (61%) patients had successful bilateral mapping. Among seven surgeons, a plateau in rates of successful bilateral mapping was achieved after 40 cases. No linear correlation was seen between the number of surgeries performed and the rate of removal of lymph node-containing tissue among surgeons. Each additional 10 procedures performed was associated with a 5% and an 11% increase in the odds of successful SLN mapping and removal of lymph node-containing tissue, respectively. DISCUSSION: The successful removal of lymph node-containing specimens appears to be a surgeon-specific phenomenon. The plateau of the learning curve for successful bilateral mapping seems to be reached at around 40 cases. These first 40 cases offer a time for auditing of individual rates of SLN mapping and removal to identify surgeons who may benefit from procedure-specific remediation. © IGCS and ESGO 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  sentinel lymph node; surgical procedures, operative; uterine cancer

Year:  2020        PMID: 31911534     DOI: 10.1136/ijgc-2019-000942

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  7 in total

1.  Sentinel Lymph Node Biopsy in Endometrial Cancer: Dual Injection, Dual Tracer-A Multidisciplinary Exhaustive Approach to Nodal Staging.

Authors:  Anna Torrent; Joana Amengual; Catalina Maria Sampol; Mario Ruiz; Jorge Rioja; Gabriel Matheu; Pilar Roca; Octavi Cordoba
Journal:  Cancers (Basel)       Date:  2022-02-13       Impact factor: 6.639

2.  Predictors for the Recurrence of Clinically Uterine-Confined Endometrial Cancer and the Role of Cytokeratin Immunohistochemistry Stain in the Era of Sentinel Lymph Node Mapping.

Authors:  Wan-Hua Ting; Shu-Wei Hsieh; Hui-Hua Chen; Ming-Chow Wei; Ho-Hsiung Lin; Sheng-Mou Hsiao
Journal:  Cancers (Basel)       Date:  2022-04-13       Impact factor: 6.575

Review 3.  Should Endometrial Cancer Treatment Be Centralized?

Authors:  Vincenzo Dario Mandato; Andrea Palicelli; Federica Torricelli; Valentina Mastrofilippo; Chiara Leone; Vittoria Dicarlo; Alessandro Tafuni; Giacomo Santandrea; Gianluca Annunziata; Matteo Generali; Debora Pirillo; Gino Ciarlini; Lorenzo Aguzzoli
Journal:  Biology (Basel)       Date:  2022-05-18

4.  Understanding the surgeon's behaviour during robot-assisted surgery: protocol for the qualitative Behav'Robot study.

Authors:  Clément Cormi; Guillaume Parpex; Camille Julio; Fiona Ecarnot; David Laplanche; Geoffrey Vannieuwenhuyse; Antoine Duclos; Stéphane Sanchez
Journal:  BMJ Open       Date:  2022-04-07       Impact factor: 2.692

5.  Sentinel lymph node biopsy in high-risk endometrial cancer: performance, outcomes, and future avenues.

Authors:  Yoo-Na Kim; Young Tae Kim
Journal:  Obstet Gynecol Sci       Date:  2022-08-02

Review 6.  Sentinel Lymph Node Mapping in Endometrial Cancer: A Comprehensive Review.

Authors:  Lirong Zhai; Xiwen Zhang; Manhua Cui; Jianliu Wang
Journal:  Front Oncol       Date:  2021-06-29       Impact factor: 6.244

7.  Sentinel node biopsy for diagnosis of lymph node involvement in endometrial cancer.

Authors:  Hans Nagar; Nina Wietek; Richard J Goodall; Will Hughes; Mia Schmidt-Hansen; Jo Morrison
Journal:  Cochrane Database Syst Rev       Date:  2021-06-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.